ライフサイエンスコーパス: sleep latency

1 jective sleep quality, sleep efficiency, and sleep latency.

2 mplicated CG44153, Piezo, Proc-R and Rbp6 in sleep latency.

3 genetic factors that influence variation in sleep latency.

4 in 248 genes contributing to variability in sleep latency.

5 culate sleep quantity, sleep efficiency, and sleep latency.

6 eep across nights and a shorter baseline REM sleep latency.

7 receptor, Rdl(A302S), specifically decreases sleep latency.

8 netics of GABA(A) receptor signaling dictate sleep latency.

9 leep apnea was demonstrated only for reduced sleep latency.

10 tonin synthesis, pupillary light reflex, and sleep latency.

11 ion was seen between Epworth scores and mean sleep latency.

12 uration and intensity of NREMS and prolonged sleep latency.

13 e conduct a genome-wide association study of sleep latency.

14 and social media were associated with longer sleep latency.

15 egions, increased sleep times, and shortened sleep latencies.

16 normal sleep latency (>10 minutes), moderate sleep latency (5 to 10 minutes), or severe sleep latency

17 mokers, current smokers had a longer initial sleep latency (5.4 minutes, 95% confidence interval (CI)

18 Moreover, the median daytime sleep latency after two nights of sleep with subatmosphe

19 ell an individual is sleeping) and increased sleep latency (amount of time to fall asleep), suggestin

20 PSQI-J scores and actigraphy sleep latency and bed out latency improved significantly

21 Income was independently associated with sleep latency and efficiency.

22 y endpoints (Maintenance of Wakefulness Test sleep latency and Epworth Sleepiness Scale score) were m

23 Zolpidem prolongs IPSCs to decrease sleep latency and increase sleep time, effects that depe

24 In the phase II study, tasimelteon reduced sleep latency and increased sleep efficiency compared wi

25 ystemic administration of zolpidem shortened sleep latency and increased sleep time.

26 with placebo, modafinil decreased nighttime sleep latency and increased slow-wave sleep time in coca

27 and 25 nM of adenosine significantly reduced sleep latency and increased total sleep time.

28 s disrupted by methamphetamine by decreasing sleep latency and increasing sleep efficiency compared w

29 flies are resistant to the effects of CBZ on sleep latency and that mutant RDL(A302S) channels are re

30 zed by decreased total sleep time, increased sleep latency, and decreased sleep efficiency, without d

31 ariables-male sex, sleepiness, nocturnal REM sleep latency, and extent of oxygen desaturation-could r

32 period significantly reduced REM, shortened sleep latency, and increased EEG delta power in rats.

33 gat(33-1)) increased sleep amount, decreased sleep latency, and increased sleep consolidation at nigh

34 duction in plasma tryptophan concentrations, sleep latency, and REM latency, as well as increased REM

35 ates that dual use is associated with longer sleep latency, and suggests that the shared component of

36 thanol microinjections significantly reduced sleep latency, and tended (P<0.06) to increase total sle

37 imination, delayed gastric emptying, altered sleep latency, anxiety-like behavior, and age-dependent

38 piness Scale), objective sleepiness (reduced sleep latency as determined by the Multiple Sleep Latenc

39 groups of patients who were defined by mean sleep latency as having normal sleep latency (>10 minute

40 s the opposite effect on sleep; it increases sleep latency as well as decreasing sleep.

41 afinil was associated with increased daytime sleep latency, as measured by the Multiple Sleep Latency

42 l biases were observed for total sleep time, sleep latency, awakening after falling asleep, sleep eff

43 PAG astrocytes, or vPAG(DA) neurons increase sleep latency but do not produce hyperactivity.

44 ystemic zolpidem administration also reduced sleep latency, but less so than for histamine neurons.

45 ld-derived population of flies, we calculate sleep latency, confirming significant, heritable genetic

46 phically assessed (upper or lower quartiles) sleep latency, continuity, and duration (RRs = 2.2-4.7;

47 onal tobacco, and dual use on sleep quality, sleep latency, cough, and drug use.

48 stress-induced insomnia in humans: increased sleep latency, decreased non-REM (nREM) and REM sleep, i

49 ir potential associations with self-reported sleep (latency, duration, and quality).

50 These experiments uncouple the regulation of sleep latency from that of sleep duration and suggest th

51 fined by mean sleep latency as having normal sleep latency (>10 minutes), moderate sleep latency (5 t

52 slow-wave sleep time, total sleep time, and sleep latency in cocaine-dependent and healthy participa

53 desensitization, underlies the regulation of sleep latency in flies.

54 naptic neuronal protein, was associated with sleep latency in the multiple sleep latency test.

55 with longer total sleep time and shorter REM sleep latency in the third week of abstinence.

56 TTX significantly shortened sleep latency, increased NREM time, decreased REM time,

57 positive affect, COVID-19-related worry, and sleep (latency, inertia, duration).

58 ore and after sleep onset, such as prolonged sleep latency, loss of stage 3-4 sleep, reduced rapid ey

59 An MSLT mean sleep latency < or =8 min and > or =2 SOREMPs (diagnosti

60 Patients with narcolepsy with mean sleep latency <25 minutes on the Maintenance of Wakefuln

61 e sleep latency (5 to 10 minutes), or severe sleep latency (<5 minutes) (analysis of variance, P = 0.

62 with an objective criterion for EDS: a mean sleep latency (MSL) < 10 min.

63 cy, sleep onset and rapid eye movement [REM] sleep latencies, non-REM and REM sleep stages, and wakef

64 hted effect sizes for subjective measures of sleep latency, number of awakenings, wake time after sle

65 Epworth Sleepiness Scale scores and mean sleep latency on the multiple sleep latency test.

66 ), a 5-min decrease in the MSLT-derived mean sleep latency (OR = 1.9, 95% CI = 1.3 to 2.8), a 90-min

67 s with Parkinson disease exhibited increased sleep latency (P = .04), reduced sleep efficiency (P = .

68 7601612 with polysomnographically determined sleep latency (P = 0.002).

69 ion was seen between Epworth scores and mean sleep latency (Pearson correlation, -0.17 [95% CI, -0.35

70 takes the view on insomnia, i.e., prolonged sleep latency, problems to maintain sleep, and early mor

71 tional tobacco was associated with increased sleep latency relative to non-smokers/non-vapers by mult

72 In many patients, a short rapid eye movement sleep latency (REML) during the NPSG is also observed bu

73 n ICU patients is characterized by prolonged sleep latencies, sleep fragmentation, decreased sleep ef

74 bal sleep quality, subjective sleep quality, sleep latency, sleep duration, sleep efficacy, sleep med

75 In the phase III study, tasimelteon improved sleep latency, sleep efficiency, and wake after sleep on

76 ality, sleep architecture (total sleep time, sleep latency, sleep efficiency, nonrapid eye movement,

77 rsomnolence was quantified with the multiple sleep latency test (MSLT) and survival analysis was used

78 deficiency, is diagnosed using the Multiple Sleep Latency Test (MSLT) following nocturnal polysomnog

79 ent (REM) periods (2omSOREMPs) on a Multiple Sleep Latency Test (MSLT) raise the possibility of narco

80 The Multiple Sleep Latency Test (MSLT) remains an important diagnosti

81 ts with cataplexy but with a normal multiple sleep latency test (MSLT) result, or if MSLT is not inte

82 et REM periods (SOREMPs) during the Multiple Sleep Latency Test (MSLT).

83 tive sleepiness was assessed by the Multiple Sleep Latency Test in all subjects, problem sleepiness b

84 Sleepiness Scale and the objective multiple sleep latency test may evaluate different, complementary

85 The Multiple Sleep Latency Test was performed at 11:30 a.m., 2:00 p.m

86 sleep latency as determined by the Multiple Sleep Latency Test), and neurobehavioral functioning (la

87 rements included polysomnography, a multiple sleep latency test, an oral glucose tolerance test, dete

88 e sleep latency, as measured by the Multiple Sleep Latency Test, and a nearly significant decrease in

89 tory tests such as polysomnography, multiple sleep latency test, and actigraphy, along with referral

90 However, in a multiple sleep latency test, the cage change group showed signifi

91 ormed with the use of the nighttime Multiple Sleep Latency Test, the Clinical Global Impression of Ch

92 ssociated with sleep latency in the multiple sleep latency test.

93 t-day sleepiness as measured by the multiple sleep latency test.

94 ic leg movement; and results of the multiple sleep latency test.

95 cores and mean sleep latency on the multiple sleep latency test.

96 s 1.5 minutes +/- 39 seconds on the Multiple Sleep Latency Test.

97 Polysomnography and multiple sleep latency testing are used to diagnose these disorde

98 me, 2 nights of polysomnography and multiple sleep latency tests in the laboratory, and body composit

99 age change group showed significantly longer sleep latencies than the gentle handling group, indicati

100 r therapy resulted in a greater reduction in sleep latency than pharmacotherapy.

101 ent from baseline in mean (+/-SEM) nighttime sleep latency (the interval between the time a person at

102 Sleep latency, the amount of time that it takes an indiv

103 oring and sleep logs to measure time in bed, sleep latency (time required to fall asleep), sleep dura

104 at Weeks 1 and 4 (p < 0.001) and in multiple sleep latency times (MSLT) at Week 4 (p < 0.05).

105 sleep, and with increases in latency to REM sleep, latency to persistent sleep, and percent Stage 3/

106 The number of awakenings per hour of sleep, latency to sleep onset, and percent Stage 1 sleep

107 Sleep latency varies considerably both among and within

108 The mean sleep latency was 1.5 minutes +/- 39 seconds on the Mult

109 5 (standard deviation (SD), 1.2) hours, mean sleep latency was 21.9 (SD, 29.0) minutes, mean sleep du

110 parameters, sleep efficiency was higher and sleep latency was shorter with radiant cooling.

111 Initial sleep latency was significantly longer in affected subje

112 In older people sleep latencies were longer close to the crest of the me

113 Sleep latencies were longest just before the onset of me

114 e the onset of melatonin secretion and short sleep latencies were observed close to the temperature n

115 eye movement (REM) sleep and shortened NREM sleep latency with a simultaneous decrease in core tempe